These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25914762)

  • 1. New insights into pancreatic cancer stem cells.
    Rao CV; Mohammed A
    World J Stem Cells; 2015 Apr; 7(3):547-55. PubMed ID: 25914762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in pancreatic cancer: biology, treatment, and prevention.
    Singh D; Upadhyay G; Srivastava RK; Shankar S
    Biochim Biophys Acta; 2015 Aug; 1856(1):13-27. PubMed ID: 25977074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting pancreatic cancer stem cells for cancer therapy.
    Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
    Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer.
    Subramaniam D; Kaushik G; Dandawate P; Anant S
    Curr Med Chem; 2018; 25(22):2585-2594. PubMed ID: 28137215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Dietary Cancer-Preventive Phytochemicals in Pancreatic Cancer Stem Cells.
    Kumar G; Farooqui M; Rao CV
    Curr Pharmacol Rep; 2018 Aug; 4(4):326-335. PubMed ID: 30560046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doublecortin-Like Kinase 1 (DCLK1) Regulates B Cell-Specific Moloney Murine Leukemia Virus Insertion Site 1 (Bmi-1) and is Associated with Metastasis and Prognosis in Pancreatic Cancer.
    Li J; Wang Y; Ge J; Li W; Yin L; Zhao Z; Liu S; Qin H; Yang J; Wang L; Ni B; Liu Y; Wang H
    Cell Physiol Biochem; 2018; 51(1):262-277. PubMed ID: 30453285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
    Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
    Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic Cancer.
    Zhao J; Li J; Schlößer HA; Popp F; Popp MC; Alakus H; Jauch KW; Bruns CJ; Zhao Y
    Stem Cells Int; 2017; 2017():6012810. PubMed ID: 28845161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ever-changing landscape of pancreatic cancer stem cells.
    Sancho P; Alcala S; Usachov V; Hermann PC; Sainz B
    Pancreatology; 2016; 16(4):489-96. PubMed ID: 27161173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of Dclk1 in the pathogenesis, diagnosis, prognosis and treatment of pancreatic cancer: A review.
    Wang Y; Yi J; Liu X
    Expert Rev Gastroenterol Hepatol; 2022 Jan; 16(1):13-19. PubMed ID: 34937474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine-mediated cancer stem cell therapy.
    Shen S; Xia JX; Wang J
    Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells and oral cancer: insights into molecular mechanisms and therapeutic approaches.
    Baniebrahimi G; Mir F; Khanmohammadi R
    Cancer Cell Int; 2020; 20():113. PubMed ID: 32280305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
    Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
    Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells.
    Fitzgerald TL; Lertpiriyapong K; Cocco L; Martelli AM; Libra M; Candido S; Montalto G; Cervello M; Steelman L; Abrams SL; McCubrey JA
    Adv Biol Regul; 2015 Sep; 59():65-81. PubMed ID: 26257206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic cancer stem cells: new insight into a stubborn disease.
    Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
    Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells as a potential therapeutic target in breast cancer.
    Zhang M; Li Z; Zhang X; Chang Y
    Stem Cell Investig; 2014; 1():14. PubMed ID: 27358860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and therapeutic implications of cancer stem cell biology.
    Cheng L; Alexander R; Zhang S; Pan CX; MacLennan GT; Lopez-Beltran A; Montironi R
    Expert Rev Anticancer Ther; 2011 Jul; 11(7):1131-43. PubMed ID: 21806335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.
    Cao Z; Weygant N; Chandrakesan P; Houchen CW; Peng J; Qu D
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33348546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.